Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients

Clinical trial NCT00562224 · COMPLETED

Trial details

NCT number: NCT00562224
Sponsor: Pharmacyclics LLC.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms by Site Lymphoma, Non-hodgkin Hodgkin Disease Multiple Myeloma Leukemia, Lymphocytic, Chronic

Start date: 2007-11-01
Primary completion: 2010-06-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.